Sangamo Therapeutics Inc. buy Barclays PLC
Start price
14.05.25
/
50%
€0.41
Target price
14.05.26
€4.47
Performance (%)
-36.22%
Price
02.04.26
€0.26
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Sangamo Therapeutics Inc. is performing very badly with a performance of -36.22%. This prediction currently runs until 14.05.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sangamo Therapeutics Inc. | -12.659% | -12.659% |
| iShares Core DAX® | 2,49 % | -5,94 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % |
| iShares S&P 500 | 1,35 % | -2,94 % |
Comments by Barclays_PLC for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Barclays PLC from $9.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
Stopped prediction by Barclays_PLC for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.12
14.11.24
14.11.24
€8.52
14.11.25
14.11.25
-81.54%
15.11.25
15.11.25
